Skip to main content

2023 SSO Annual Meeting Main banner

Tweets by 2023 SSO Annual Meeting

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Tweet

HPB Great Debate: Neoadjuvant Therapy Should be Routinely Given for High-risk Intrahepatic Cholangiocarcinoma

PRO: Neoadjuvant Therapy Should be Routinely Given for High-risk Intrahepatic Cholangiocarcinoma

Saturday, March 25, 2023

8:40 AM – 8:57 AM

Location: Ballroom A

Debater(s)

Hop S. Tran Cao, MD (he/him/his)

Associate Professor of Surgery
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States

Disclosure(s): Intuitive Surgical: Research Grant (Ongoing)

Disclosure(s):

Hop S. Tran Cao, MD: Intuitive Surgical: Research Grant (Ongoing)